参考文献:[1]Sonam Puri, Andreas Saltos, Bradford Perez, et al. Locally Advanced, Unresectable Non-Small Cell Lung Cancer. Current Oncology Reports (2020) 22:31.[2]A. Romero, R. Serna, E. Nadal, et al. Pre-treatment ctDNA Levels Significantly Predicts of OS and PFS in NADIM II Trial. 2022WCLC. MA06.03.[3]W.E.E. Eberhardt, C. Poettgen, T.C. Gauler, et al. Long-term Survival and Competing Risks of Death in the ESPATUE Randomized Phase-III Trial in Stage III NSCLC. 2022WCLC. MA06.08.[4]Y. Zhong, Y. She, J. Deng, C. Chen. Deep Learning for Predicting MPR to Neoadjuvant Immunotherapy in NSCLC. 2022WCLC. MA06.09.